Health Innovation Euregion 2025

12 Jun 2025 | Netherlands

Brightlands Venture Partners

Company

brightlandsventurepartners.com/Geleen, Netherlands
10 profile visits

About

BVP is a venture capital fund manager that invests in innovative start-up companies that provide solutions for societal challenges related to sustainability and health.

We believe that start-ups have a crucial role to play in future-proofing the chemical, agricultural and healthcare industries. Our mission is to support such start-ups by providing them with access to growth capital, our deep sector expertise, and decades of investment experience, as well as our vast network.

Thematic Focus

It is our goal to accelerate sustainable businesses that address and solve major environmental & health challenges. We focus on the following sectors:

  • Renewable Chemistry & Circularity

  • HealthTech & Life Sciences

  • Agritech & Food

We invest across the entire continuum of hardware and software.

Our investment criteria

We are always looking for new investment opportunities that have the following characteristics:

  • Top-notch team

  • Breakthrough proprietary technology

  • Strong growth ambition

  • Credible business model

  • Exit horizon < 7 years

  • Seed – Series A stage

  • €250k – €2M initial ticket size

  • Based in Europe

What can you expect from us

We are a high-conviction investor. We invest in a limited number of companies in which we have a strong belief. Our strategy is that we:

  • Actively support our portfolio companies by adding strategic value leveraging our deep sector expertise and vast investing experience. In addition, we facilitate connections with relevant co-investors and key opinion leaders.

  • Can assume the role of lead investor. We are equally comfortable to co-invest.

  • Reserve a significant amount for follow-on investments, to support our portfolio companies in future funding rounds.

E-HEALTH

Safety & systemsSensors & Wireless productsHealth information managementRemote diagnosticsOthers

GENOME RESEARCH

BioinformaticsGene Expression, Proteome ResearchPopulation genetics

LIFE SCIENCE

Diagnosticse-Health and ICT solutionsEmergency Medicine, Rescue EquipmentHospital and Care equipmentImaging processingIntense medicine, Anaesthesiology, RespirationLaboratory EquipmentMedical ServicesOperating technology and equipmentPhysiotherapy, Orthopaedic TechnologySterilisationSurgery and EndoscopyTherapy and physical medicine

THERAPEUTIC AREA

Cardiology/Vascular DiseasesDental & Oral HealthDermatologyDiagnosticsEndocrinologyGastroenterologyGenetic DiseaseHematologyHepatologyImmunologyInfections and Infectious DiseasesInternal MedicineMusculoskeletalNephrologyNeurologyNutrition and Weight LossObstetrics/GynecologyOncologyOphthalmologyOrthopedics/Orthopedic SurgeryOtolaryngologyPediatrics/NeonatologyPharmacology/ToxicologyPodiatryPsychiatry/PsychologyPulmonary/Respiratory DiseasesRare DiseaseRheumatologyTraumaUrologyVaccines

MEDICINE

Biostatistics, EpidemiologyClinical Research, TrialsCytology, Cancerology, OncologyDentistry / Odontology, StomatologyDiagnostics, DiagnosisEmergency medicineEnvironmental Medicine, Social Medicine, Sports MedicineGene - DNA TherapyGerontology and GeriatricsHeart and blood circulation illnessesHuman vaccinesMedical BiomaterialsMedical FurnitureMedical ResearchMedical Technology / Biomedical EngineeringMedical TextilesNeurology, Brain ResearchPharmaceutical Products / DrugsPhysiologyPhysiotherapy, Orthopaedic TechnologySingle Use Products and Consumer GoodsStem cell TechnologiesSurgeryVirology/Antibiotics/Bacteriology

VALUE CHAIN

Investment/ Financing

Representatives

Luc Starmans

Partner

Brightlands Venture Partners